What does the long-term liver allograft look like for the pediatric recipient?

Liver Transplantation

Volumn 15, Issue SUPPL. 2, 2009, Pages

  Hübscher, Stefan ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ALLOGRAFT; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER GRAFT; PATIENT COMPLIANCE; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TREATMENT REFUSAL; ALLOTRANSPLANTATION; BIOPSY; CHILD; FOLLOW UP; GRAFT SURVIVAL; LIVER; LIVER TRANSPLANTATION; METHODOLOGY; PATHOLOGY; REVIEW; TIME; TREATMENT OUTCOME;

BIOPSY; CHILD; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LIVER; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77449131297     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21902     Document Type: Article

References (22)

1. Ng VL, Fecteau A, Shepherd R, Magee J, Bucuvalas J, Alonso E, et al. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a North American multicenter registry. Pediatrics 2008; 122: e1128-e1135.
2. Hubscher SG, Portmann BC,. Transplantation pathology. In:, Burt AD, Portmann BC, Ferrell LD, eds. MacSween's Pathology of the Liver. 5th ed. Edinburgh, United Kingdom: Churchill Livingstone; 2007: 815-879.
3. Hubscher SG,. Transplantation pathology. Semin Liver Dis 2009; 29: 74-90.
4. Fouquet V, Alves A, Branchereau S, Grabar S, Debray D, Jacquemin E, et al. Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl 2005; 11: 152-160. (Pubitemid 40268212)
5. Evans HM, Kelly DA, McKiernan PJ, Hubscher S,. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006; 43: 1109-1117. (Pubitemid 43724635)
6. Ekong UD, Melin-Aldana H, Seshadri R, Lokar J, Harris D, Whitington PF, et al. Graft histology characteristics in long-term survivors of pediatric liver transplantation. Liver Transpl 2008; 14: 1582-1587.
7. Scheenstra R, Peeters PM, Verkade HJ, Gouw AS,. Graft fibrosis after pediatric liver transplantation: ten years of follow-up. Hepatology 2009; 49: 880-886.
8. Venkat VL, Nick TG, Wang Y, Bucuvalas JC,. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence. Pediatr Transplant 2008; 12: 67-72.
9. Demetris AJ, Adeyi O, Bellamy CO, Clouston A, Charlotte F, Czaja A, et al. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006; 44: 489-501.
10. Sundaram SS, Melin-Aldana H, Neighbors K, Alonso EM,. Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients. Liver Transpl 2006; 12: 58-64.
11. Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT,. Significance of central perivenulitis in pediatric liver transplantation. Am J Surg Pathol 2008; 32: 1479-1488.
12. Hubscher SG,. Central perivenulitis: a common and potentially important finding in late posttransplant liver biopsies. Liver Transpl 2008; 14: 596-600.
13. Jain A, Costa G, Marsh W, Fontes P, Devera M, Mazariegos G, et al. Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-term follow-up in 1000 consecutive patients. Transpl Int 2006; 19: 27-37.
14. Avitzur Y, Ngan BY, Lao M, Fecteau A, Ng VL,. Prospective evaluation of the prevalence and clinical significance of positive autoantibodies after pediatric liver transplantation. J Pediatr Gastroenterol Nutr 2007; 45: 222-227. (Pubitemid 47220531)
15. Richter A, Grabhorn E, Helmke K, Manns MP, Ganschow R, Burdelski M,. Clinical relevance of autoantibodies after pediatric liver transplantation. Clin Transplant 2007; 21: 427-432. (Pubitemid 46711410)
16. Demetris AJ, Sebagh M,. Plasma cell hepatitis in liver allografts: variant of rejection or autoimmune hepatitis? Liver Transpl 2008; 14: 750-755. (Pubitemid 351895504)
17. Mells G, Neuberger J,. Protocol liver allograft biopsies. Transplantation 2008; 85: 1686-1692.
18. Shaikh OS, Demetris AJ,. Idiopathic posttransplantation hepatitis? Liver Transpl 2007; 13: 943-946.
19. Herzog D, Soglio DB, Fournet JC, Martin S, Marleau D, Alvarez F,. Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients. Liver Transpl 2008; 14: 946-955. (Pubitemid 352003893)
20. Peeters PM, Sieders E, vd Heuvel M, Bijleveld CM, de Jong KP, TenVergert EM, et al. Predictive factors for portal fibrosis in pediatric liver transplant recipients. Transplantation 2000; 70: 1581-1587. (Pubitemid 32037970)
21. Devarbhavi H, Abraham S, Kamath PS,. Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation. Liver Transpl 2007; 13: 1552-1556. (Pubitemid 350168196)
22. Huang R, Schiano TD, Amolat MJ, Miller CM, Thung SN, Saxena R,. Hepatocellular proliferation and changes in microarchitecture of right lobe allografts in adult transplant recipients. Liver Transpl 2004; 10: 1461-1467. (Pubitemid 40028377)